SIGNORILE e FERRI: Brevettabilità dei farmaci

This procedure concerns the rules for granting patents for pharmaceutical products. It aims to balance innovation incentives with public access to medicines. It affects pharmaceutical companies, researchers, and patients by influencing the availability and cost of new drugs.